Your shopping cart is currently empty

ABAI-30 is a highly potent and orally bioavailable anti-inflammatory compound that efficiently suppresses nitric oxide (NO) production in lipopolysaccharide (LPS) activated RAW264.7 cells [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | ABAI-30 is a highly potent and orally bioavailable anti-inflammatory compound that efficiently suppresses nitric oxide (NO) production in lipopolysaccharide (LPS) activated RAW264.7 cells [1]. |
| In vitro | In RAW264.7 cells, ABAI-30 at concentrations ranging from 10-40 µM suppresses the TLR4-pp65 and NLRP3-caspase-1 signaling pathways, resulting in the decreased expression of IL6, IL-1β, and TNFα at both the transcriptional and translational levels [1]. |
| In vivo | In a mouse model of dextran sulfate sodium (DSS)-induced colitis, ABAI-30, administered orally at a dosage of 25 mg/kg for 5 days, exhibited significant in vivo anti-inflammatory effects with no evident toxicity [1]. |
| Molecular Weight | 347.33 |
| Formula | C17H13N7O2 |
| Cas No. | 2757957-25-6 |
| Smiles | C(NNC(=O)C1=CC=CC=N1)(=O)C=2NC(C=3C=4C(NC3)=NC=CC4)=NC2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.